Cargando…

Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer

BACKGROUND: Cyclophosphamide is a potent anticancer drug, but its clinical utility is limited because of its severe side effects, in particular liver damage. Chalone 19-peptide induces apoptosis of tumor cells and inhibits tumor growth. The present study investigated the antitumor effects of a combi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yuanxi, He, Yan, Ye, Shengqian, Li, Xiaomei, Zhong, Qingqi, Chen, Zhuo, Jin, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712081/ https://www.ncbi.nlm.nih.gov/pubmed/23874108 http://dx.doi.org/10.2147/OTT.S44564

Ejemplares similares

Myostatin: A Skeletal Muscle Chalone
por: Lee, Se-Jin
Publicado: (2023)

Synthesis Chalones and Their Isomerization into Flavanones and Azaflavanones
por: Rocha, Djenisa H. A., et al.
Publicado: (2019)

A Dictyostelium chalone uses G proteins to regulate proliferation
por: Bakthavatsalam, Deenadayalan, et al.
Publicado: (2009)

Chalone-like effect abrogated by dextran sulphate and heparin polyanion pretreatment of target cells.
por: Ebbesen, P., et al.
Publicado: (1975)

Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin
por: Wang, Shuai, et al.
Publicado: (2018)

Combination therapy of tacrolimus, high doses of glucocorticosteroids, and cyclophosphamide against existing historical treatment for patients in severe conditions of interstitial lung diseases complicated with dermatomyositis: A retrospective analysis
por: Li, Lian, et al.
Publicado: (2022)

Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
por: Wang, Jing, et al.
Publicado: (2022)

Effects of collagen peptides from Micropterus salmoides skin on oxidative damage induced by cyclophosphamide in mice
por: Han, Mengyao, et al.
Publicado: (2022)

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
por: Liu, Deyue, et al.
Publicado: (2022)

Naringenin ameliorates Cyclophosphamide-induced nephrotoxicity in experimental model
por: Alaqeel, Nouf K., et al.
Publicado: (2023)

The cytotoxicity of cyclophosphamide is enhanced in combination with monascus pigment
por: Kurokawa, Hiromi, et al.
Publicado: (2021)

Cyclophosphamide mechanism of action in preclinical tecemotide studies
por: Hance, Ken, et al.
Publicado: (2013)

Evaluation of Cyclophosphamide Dosage Schedules in Breast Cancer
por: Stoll, B. A.
Publicado: (1970)

Immunomodulatory effects of selenium‐enriched peptides from soybean in cyclophosphamide‐induced immunosuppressed mice
por: Zhang, Jian, et al.
Publicado: (2021)

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
por: Vasey, P A, et al.
Publicado: (2002)

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
por: Orlando, Laura, et al.
Publicado: (2006)

Carnosine attenuates cyclophosphamide-induced bone marrow suppression by reducing oxidative DNA damage
por: Deng, Jie, et al.
Publicado: (2017)

Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil
por: De Bruijn, Ernst A., et al.
Publicado: (1992)

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
por: Zhang, Minmin, et al.
Publicado: (2016)

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer
por: Adeel, Muhammad, et al.
Publicado: (2019)

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
por: Bazzola, L, et al.
Publicado: (2015)

Atorvastatin attenuates the ovarian damage induced by cyclophosphamide in rat: An experimental study
por: Hamzeh, Maedeh, et al.
Publicado: (2018)

Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei
por: Zhang, Ying, et al.
Publicado: (2023)

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study
por: Russo, Francesco, et al.
Publicado: (2013)

Multi‐drug Combination Therapy with Vincristine‐Melphalan‐Cyclophosphamide‐Prednisolone Was More Effective than Cyclophosphamide‐Prednisolone in Stage III Myeloma
por: Shimizu, Kazuyuki, et al.
Publicado: (1990)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)

Combination Chemotherapy with Nedaplatin and Cyclophosphamide in Human Ovarian Cancer Model
por: Uchida, Naomi, et al.
Publicado: (1999)

Cardanol: toxicogenetic assessment and its effects when combined with cyclophosphamide
por: Schneider, Beatriz Ursinos Catelan, et al.
Publicado: (2016)

Synergistic Antitumor Effect of Grifola frondose Polysaccharide—Protein Complex in Combination with Cyclophosphamide in H22 Tumor-Bearing Mice
por: Zhao, Jiahui, et al.
Publicado: (2023)

Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients
por: Chen, Lu, et al.
Publicado: (2018)

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
por: Moon, Yong Wha, et al.
Publicado: (2013)

Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.
por: Rubens, R. D., et al.
Publicado: (1975)

Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer
por: Soriano, Jorge L., et al.
Publicado: (2011)

Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
por: Cai, Hui, et al.
Publicado: (2019)

Cyclophosphamide-induced testicular toxicity ameliorate by American ginseng treatment: An experimental study
por: Hosseini, Akram, et al.
Publicado: (2018)

The therapeutic potential of amifostine on cyclophosphamide-induced testicular dysfunction in rats: An experimental study
por: Kaya, Coskun, et al.
Publicado: (2019)

Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus
por: Wolf, Victoria L., et al.
Publicado: (2019)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bs6i3hu4vl1aoelpr0th06n4r